Biognosys at US HUPO 17th Annual Conference 2021 - Biognosys

Biognosys at US HUPO 17th Annual Conference 2021


Simplify your Targeted Proteomics Analysis with SpectroDive

US HUPO 2021 Seminar | Wednesday, March 10th at 2.00 PM (ET) / 8.00 PM (CET)

Targeted proteomics focuses on the measurement of a selected set of proteins that need to be quantified with high sensitivity, quantitative accuracy, and reproducibility. With SpectroDive 10, it is easier than ever to quantify target proteins thanks to a streamlined panel generation process and reliable automated peptide identification. We are hosting two speakers as part of this seminar.


In our first presentation, Tejas Gandhi from Biognosys will introduce the new, seamless SureQuant integration and demonstrate how SpectroDive can boost your productivity for targeted proteomics workflows, especially when analyzing large-scale datasets.


In the second presentation, Simone Di Sanzo from Alessandro Ori’s lab will share their latest research on mapping sites of carboxymethyllysine modification in proteins to reveal associated consequences for proteostasis and cell proliferation. Posttranslational mechanisms play a key role in modifying the abundance and function of cellular proteins. Among these, modification by advanced glycation end products (AGEs) has been shown to accumulate during aging and age-associated diseases but specific protein targets remain largely unexplored. The Ori lab devised a proteomic strategy to identify specific sites of carboxymethyllysine (CML) modification, one of the most abundant AGEs, and precisely quantify changes of abundance in a site-specific manner by PRM.





Tejas Gandhi, Biognosys

Tejas received his PhD in Bioinformatics in 2011 from the University of Groningen, the Netherlands. He then joined Biognosys and became a key contributor to different software products, including as lead developer of SpectroDive. As Head of Bioinformatics, he leads a highly motivated team of scientists and bioinformaticians in building better software solutions for mass spec-based proteomics.


Simone Di Sanzo, Leibniz Institute on Aging

Simone obtained a Master degree in medical biotechnologies at the University of Milano-Bicocca, Italy. For his PhD, he joined Alessandro Ori’s lab at the Leibniz Institute on Aging – FLI, Jena, Germany, as part of the ProMoAge graduate program funded by the German research foundation (DFG). Simone’s work focuses on using mass spectrometry-based proteomics to study protein post-translational modifications, in particular Advanced Glycation End Products, in the context of aging.


Maximilian Helf, Biognosys



    Close banner

    New: Spectronaut® 19

    Unlock Your Data's True Story

    New: Spectronaut® 19

    Unlock Your Data's True Story

    Learn More